These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 1400073

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of von Willebrand's disease.
    Mannucci PM.
    J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Management of inherited von Willebrand disease in 2007.
    Federici AB, Mannucci PM.
    Ann Med; 2007; 39(5):346-58. PubMed ID: 17701477
    [Abstract] [Full Text] [Related]

  • 7. [Desmopressin in hemophilia A and Von Willebrand's disease].
    Castro Cabezas M, de Graaf JC, Kraayenhagen RJ, Freen M, Poortman J, Hart HC.
    Ned Tijdschr Geneeskd; 1991 Mar 02; 135(9):367-71. PubMed ID: 1901629
    [Abstract] [Full Text] [Related]

  • 8. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U.
    Clin Appl Thromb Hemost; 2007 Jan 02; 13(1):14-34. PubMed ID: 17164493
    [Abstract] [Full Text] [Related]

  • 9. von Willebrand disease: from the bedside to therapy.
    Aledort LM.
    Thromb Haemost; 1997 Jul 02; 78(1):562-5. PubMed ID: 9198216
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.
    Franchini M, Rossetti G, Tagliaferri A, Pattacini C, Pozzoli D, Lippi G, Manzato F, Bertuzzo D, Gandini G.
    Haematologica; 2003 Nov 02; 88(11):1279-83. PubMed ID: 14607757
    [Abstract] [Full Text] [Related]

  • 11. [Perioperative therapy of von Willebrand disease. Demonstration of pathophysiology, clinical problems and therapy options using two case reports].
    Kleinschmidt S, Fuchs-Buder T, Wilhelm W, Seyfert UT, Mörsdorf S.
    Anaesthesist; 2002 Oct 02; 51(10):825-34. PubMed ID: 12395174
    [Abstract] [Full Text] [Related]

  • 12. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
    van Vliet HH, Kappers-Klunne MC, Leebeek FW, Michiels JJ.
    Thromb Haemost; 2008 Sep 02; 100(3):462-8. PubMed ID: 18766263
    [Abstract] [Full Text] [Related]

  • 13. [An inherited hemostatic disorder as the cause of menorrhagia].
    Leebeek FW, Lotgering FK.
    Ned Tijdschr Geneeskd; 2002 Mar 23; 146(12):545-8. PubMed ID: 11938574
    [Abstract] [Full Text] [Related]

  • 14. von Willebrand disease and pregnancy: a practical approach for the diagnosis and treatment.
    Pacheco LD, Costantine MM, Saade GR, Mucowski S, Hankins GD, Sciscione AC.
    Am J Obstet Gynecol; 2010 Sep 23; 203(3):194-200. PubMed ID: 20417473
    [Abstract] [Full Text] [Related]

  • 15. Von Willebrand's disease: clinical management.
    Federici AB, Castaman G, Thompson A, Berntorp E.
    Haemophilia; 2006 Jul 23; 12 Suppl 3():152-8. PubMed ID: 16684011
    [Abstract] [Full Text] [Related]

  • 16. Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3.
    Michiels JJ, Gadisseur A, van der Planken M, Schroyens W, van de Velden A, Berneman Z.
    Semin Thromb Hemost; 2006 Sep 23; 32(6):636-45. PubMed ID: 16977574
    [Abstract] [Full Text] [Related]

  • 17. [Von Willebrand's disease].
    Furlan M.
    Schweiz Med Wochenschr; 1987 Nov 14; 117(46):1798-806. PubMed ID: 3122318
    [Abstract] [Full Text] [Related]

  • 18. Management of von Willebrand's disease.
    Logan LJ.
    Prog Clin Biol Res; 1990 Nov 14; 324():279-90. PubMed ID: 2106690
    [No Abstract] [Full Text] [Related]

  • 19. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A, Berneman Z, Schroyens W, Michiels JJ.
    Acta Haematol; 2009 Nov 14; 121(2-3):128-38. PubMed ID: 19506359
    [Abstract] [Full Text] [Related]

  • 20. [Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease].
    Fukui H, Takase T.
    Rinsho Ketsueki; 1985 Jul 14; 26(7):1069-79. PubMed ID: 3932720
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.